Standard BioTools Net Profit Margin 2010-2024 | LAB
Standard BioTools net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Standard BioTools Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-06-30 |
$0.14B |
$-0.17B |
-121.32% |
| 2024-03-31 |
$0.13B |
$-0.14B |
-107.09% |
| 2023-12-31 |
$0.11B |
$-0.08B |
-70.75% |
| 2023-09-30 |
$0.11B |
$-0.08B |
-72.38% |
| 2023-06-30 |
$0.11B |
$-0.08B |
-79.25% |
| 2023-03-31 |
$0.10B |
$-0.13B |
-135.05% |
| 2022-12-31 |
$0.10B |
$-0.19B |
-191.92% |
| 2022-09-30 |
$0.11B |
$-0.18B |
-161.82% |
| 2022-06-30 |
$0.11B |
$-0.16B |
-144.25% |
| 2022-03-31 |
$0.13B |
$-0.12B |
-92.80% |
| 2021-12-31 |
$0.13B |
$-0.06B |
-45.04% |
| 2021-09-30 |
$0.14B |
$-0.07B |
-49.28% |
| 2021-06-30 |
$0.15B |
$-0.06B |
-40.27% |
| 2021-03-31 |
$0.14B |
$-0.06B |
-38.89% |
| 2020-12-31 |
$0.14B |
$-0.05B |
-38.13% |
| 2020-09-30 |
$0.13B |
$-0.05B |
-38.10% |
| 2020-06-30 |
$0.11B |
$-0.06B |
-49.11% |
| 2020-03-31 |
$0.11B |
$-0.06B |
-49.12% |
| 2019-12-31 |
$0.12B |
$-0.07B |
-56.03% |
| 2019-09-30 |
$0.12B |
$-0.07B |
-57.76% |
| 2019-06-30 |
$0.12B |
$-0.07B |
-57.98% |
| 2019-03-31 |
$0.12B |
$-0.07B |
-60.68% |
| 2018-12-31 |
$0.11B |
$-0.06B |
-52.68% |
| 2018-09-30 |
$0.11B |
$-0.05B |
-50.00% |
| 2018-06-30 |
$0.10B |
$-0.06B |
-52.88% |
| 2018-03-31 |
$0.10B |
$-0.06B |
-54.90% |
| 2017-12-31 |
$0.10B |
$-0.06B |
-58.25% |
| 2017-09-30 |
$0.10B |
$-0.07B |
-68.00% |
| 2017-06-30 |
$0.10B |
$-0.07B |
-74.23% |
| 2017-03-31 |
$0.10B |
$-0.07B |
-73.27% |
| 2016-12-31 |
$0.10B |
$-0.08B |
-74.04% |
| 2016-09-30 |
$0.11B |
$-0.07B |
-65.45% |
| 2016-06-30 |
$0.12B |
$-0.06B |
-52.14% |
| 2016-03-31 |
$0.12B |
$-0.06B |
-48.31% |
| 2015-12-31 |
$0.12B |
$-0.05B |
-45.69% |
| 2015-09-30 |
$0.12B |
$-0.05B |
-43.22% |
| 2015-06-30 |
$0.12B |
$-0.06B |
-47.06% |
| 2015-03-31 |
$0.12B |
$-0.05B |
-45.76% |
| 2014-12-31 |
$0.12B |
$-0.05B |
-45.30% |
| 2014-09-30 |
$0.11B |
$-0.05B |
-44.76% |
| 2014-06-30 |
$0.09B |
$-0.04B |
-39.78% |
| 2014-03-31 |
$0.08B |
$-0.03B |
-34.15% |
| 2013-12-31 |
$0.07B |
$-0.02B |
-23.94% |
| 2013-09-30 |
$0.07B |
$-0.02B |
-24.24% |
| 2013-06-30 |
$0.06B |
$-0.02B |
-26.23% |
| 2013-03-31 |
$0.06B |
$-0.02B |
-29.82% |
| 2012-12-31 |
$0.05B |
$-0.02B |
-37.74% |
| 2012-09-30 |
$0.05B |
$-0.02B |
-38.00% |
| 2012-06-30 |
$0.05B |
$-0.02B |
-39.58% |
| 2012-03-31 |
$0.05B |
$-0.02B |
-45.65% |
| 2011-12-31 |
$0.04B |
$-0.03B |
-70.45% |
| 2011-09-30 |
$0.04B |
$-0.03B |
-75.61% |
| 2011-06-30 |
$0.04B |
$-0.03B |
-78.95% |
| 2011-03-31 |
$0.04B |
$-0.03B |
-80.00% |
| 2010-12-31 |
$0.03B |
$-0.02B |
-51.52% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.763B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
